Latest Insider Transactions at Amag Pharmaceuticals, Inc. (AMAG)
This section provides a real-time view of insider transactions for Amag Pharmaceuticals, Inc. (AMAG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMAG PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMAG PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Paul R. Fonteyne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anthony Casciano Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
76,349
-100.0%
|
-
|
|
Nov 16
2020
|
John A. Fallon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,362
-100.0%
|
-
|
|
Nov 16
2020
|
Brian Piekos Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,538
-100.0%
|
-
|
|
Nov 16
2020
|
Kathrine O'Brien Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,473
-100.0%
|
-
|
|
Nov 16
2020
|
Joseph Vittiglio Chief Business Officer, GC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
92,244
-100.0%
|
-
|
|
Nov 16
2020
|
James R Sulat Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,090
-100.0%
|
-
|
|
Nov 16
2020
|
Kelly Schick Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,155
-100.0%
|
-
|
|
Nov 16
2020
|
Caligan Partners LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anne M. Phillips Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Davey Scoon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,898
-100.0%
|
-
|
|
Oct 01
2020
|
Camber Capital Management LP |
SELL
Open market or private sale
|
Indirect |
4,390,000
-100.0%
|
$57,070,000
$13.57 P/Share
|
|
Mar 16
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,000
+6.45%
|
$96,000
$4.87 P/Share
|
|
Feb 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,000
+5.36%
|
$288,000
$8.29 P/Share
|
|
Jan 27
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,000
+1.35%
|
$32,000
$4.71 P/Share
|
|
Jan 27
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.19%
|
$72,000
$9.43 P/Share
|
|
Jan 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+6.25%
|
$160,000
$4.86 P/Share
|
|
Jan 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
34,000
+0.82%
|
$306,000
$9.58 P/Share
|
|
Jan 10
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 10
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
18,000
+0.44%
|
$198,000
$11.64 P/Share
|
|
Jan 09
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 09
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,466
+0.31%
|
$149,592
$12.33 P/Share
|
|
Jan 09
2020
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jan 09
2020
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,466
-0.31%
|
$149,592
$12.43 P/Share
|
|
Aug 09
2019
|
Camber Capital Management LP |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.34%
|
$270,000
$9.06 P/Share
|
|
Aug 07
2019
|
Camber Capital Management LP |
BUY
Open market or private purchase
|
Indirect |
355,000
+2.59%
|
$2,485,000
$7.7 P/Share
|
|
Aug 07
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+7.14%
|
$120,000
$3.72 P/Share
|
|
Aug 07
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
260,000
+6.02%
|
$1,820,000
$7.32 P/Share
|
|
Jun 27
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+4.55%
|
$80,000
$4.74 P/Share
|
|
Jun 27
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
44,000
+1.14%
|
$396,000
$9.52 P/Share
|
|
Jun 26
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 26
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
120,000
+3.1%
|
$1,080,000
$9.13 P/Share
|
|
Jun 25
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,000
+9.52%
|
$275,000
$5.9 P/Share
|
|
Jun 25
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
259,016
+6.65%
|
$2,072,128
$8.59 P/Share
|